Xencor, Inc Net Income (Loss) Available to Common Stockholders, Basic
Xencor, Inc (XNCR) reported Net Income (Loss) Available to Common Stockholders, Basic of -$21.73 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-08-05
- Xencor, Inc net income (loss) available to common stockholders, basic for the quarter ending 2026-06-30 was -$21.73M.
- Xencor, Inc net income (loss) available to common stockholders, basic for the quarter ending 2026-03-31 was -$128.92M.
- Xencor, Inc net income (loss) available to common stockholders, basic for the quarter ending 2025-12-31 was -$6.65M.
- Xencor, Inc net income (loss) available to common stockholders, basic for the quarter ending 2025-09-30 was -$6.03M.
- Xencor, Inc net income (loss) available to common stockholders, basic for fiscal 2025 was -$91.92M.
- Xencor, Inc net income (loss) available to common stockholders, basic for fiscal 2024 was -$232.62M.
- Xencor, Inc net income (loss) available to common stockholders, basic for fiscal 2023 was -$133.13M.
- Xencor, Inc net income (loss) available to common stockholders, basic for fiscal 2022 was -$55.18M, a 166.78% decline from fiscal 2021.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 12 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$21.73M 10-Q · filed 2026-08-05 | -$150.65M 10-Q · filed 2026-08-05 | -$157.30M derived: sum of 3 quarters · filed 2026-08-05 | -$163.32M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | -$128.92M 10-Q · filed 2026-05-06 | -$135.57M derived: sum of 2 quarters · filed 2026-05-06 | -$141.60M derived: sum of 3 quarters · filed 2026-05-06 | -$172.42M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | -$6.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$12.68M derived: sum of 2 quarters · filed 2026-02-25 | -$43.51M derived: sum of 3 quarters · filed 2026-08-05 | -$91.92M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | -$6.03M 10-Q · filed 2025-11-05 | -$36.85M derived: sum of 2 quarters · filed 2026-08-05 | -$85.27M 10-Q · filed 2025-11-05 | -$130.82M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | -$30.82M 10-Q · filed 2026-08-05 | -$79.24M 10-Q · filed 2026-08-05 | -$124.80M derived: sum of 3 quarters · filed 2026-08-05 | -$171.08M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | -$48.42M 10-Q · filed 2026-05-06 | -$93.97M derived: sum of 2 quarters · filed 2026-05-06 | -$140.26M derived: sum of 3 quarters · filed 2026-05-06 | -$207.60M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | -$45.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$91.84M derived: sum of 2 quarters · filed 2026-02-25 | -$159.18M derived: sum of 3 quarters · filed 2026-02-25 | -$232.62M 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | -$46.29M 10-Q · filed 2025-11-05 | -$45.14M 10-Q · filed 2024-11-06 | -$113.63M derived: sum of 2 quarters · filed 2025-11-05 | -$187.06M 10-Q · filed 2025-11-05 | -$179.14M 10-Q · filed 2024-11-06 | -$213.21M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-06-30 | -$67.34M 10-Q · filed 2025-08-06 | -$65.96M 10-Q · filed 2024-08-05 | -$140.78M 10-Q · filed 2025-08-06 | -$134.00M 10-Q · filed 2024-08-05 | -$166.92M derived: sum of 3 quarters · filed 2026-02-25 | -$191.19M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-03-31 | -$73.44M 10-Q · filed 2025-05-07 | -$68.03M 10-Q · filed 2024-05-09 | -$99.59M derived: sum of 2 quarters · filed 2026-02-25 | -$123.86M derived: sum of 3 quarters · filed 2026-02-25 | -$145.81M derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2023-12-31 | -$26.15M derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-02-25 | -$50.42M derived: sum of 2 quarters · filed 2026-02-25 | -$72.37M derived: sum of 3 quarters · filed 2026-02-25 | -$133.13M 10-K · filed 2026-02-25 | -$126.09M 10-K · filed 2024-02-29 | |||
| 2023-09-30 | -$24.27M 10-Q/A · filed 2025-02-24 | -$46.22M derived: sum of 2 quarters · filed 2025-02-24 | -$106.99M 10-Q/A · filed 2025-02-24 | -$119.03M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-06-30 | -$21.95M 10-Q/A · filed 2025-02-24 | -$82.72M 10-Q/A · filed 2025-02-24 | -$94.76M derived: sum of 3 quarters · filed 2025-02-27 | -$127.52M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-03-31 | -$60.76M 10-Q/A · filed 2025-02-24 | -$72.81M derived: sum of 2 quarters · filed 2025-02-27 | -$105.56M derived: sum of 3 quarters · filed 2025-02-27 | -$139.54M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2022-12-31 | -$12.04M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$44.80M derived: sum of 2 quarters · filed 2025-02-27 | -$78.78M derived: sum of 3 quarters · filed 2025-02-27 | -$55.18M 10-K · filed 2025-02-27 | ||||
| 2022-09-30 | -$32.76M 10-Q · filed 2023-11-08 | -$66.73M derived: sum of 2 quarters · filed 2023-11-08 | -$43.14M 10-Q · filed 2023-11-08 | $29.92M derived: sum of 4 quarters · filed 2025-02-24 | ||||
| 2022-06-30 | -$33.98M 10-Q · filed 2023-08-03 | -$10.38M 10-Q · filed 2023-08-03 | $62.68M derived: sum of 3 quarters · filed 2025-02-24 | $22.49M derived: sum of 4 quarters · filed 2025-02-24 | ||||
| 2022-03-31 | $23.59M 10-Q · filed 2023-05-08 | $96.66M derived: sum of 2 quarters · filed 2025-02-24 | $56.46M derived: sum of 3 quarters · filed 2025-02-24 | $108.71M derived: sum of 4 quarters · filed 2025-02-24 | ||||
| 2021-12-31 | $73.06M derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-02-24 | $32.87M derived: sum of 2 quarters · filed 2025-02-24 | $85.12M derived: sum of 3 quarters · filed 2025-02-24 | $82.63M 10-K/A · filed 2025-02-24 | ||||
| 2021-09-30 | -$40.19M 10-Q · filed 2022-11-07 | $12.06M derived: sum of 2 quarters · filed 2022-11-07 | $9.57M 10-Q · filed 2022-11-07 | -$4.12M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-06-30 | $52.25M 10-Q · filed 2022-08-03 | $49.76M 10-Q · filed 2022-08-03 | $36.07M derived: sum of 3 quarters · filed 2023-02-27 | $23.52M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-03-31 | -$2.49M 10-Q · filed 2022-05-05 | -$16.18M derived: sum of 2 quarters · filed 2023-02-27 | -$28.73M derived: sum of 3 quarters · filed 2023-02-27 | -$63.75M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2020-12-31 | -$13.69M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$26.24M derived: sum of 2 quarters · filed 2023-02-27 | -$61.26M derived: sum of 3 quarters · filed 2023-02-27 | -$69.33M 10-K · filed 2023-02-27 | ||||
| 2020-09-30 | -$12.55M 10-Q · filed 2021-11-08 | -$47.57M derived: sum of 2 quarters · filed 2021-11-08 | -$55.64M 10-Q · filed 2021-11-08 | -$82.55M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | -$35.02M 10-Q · filed 2021-08-04 | -$43.09M 10-Q · filed 2021-08-04 | -$70.00M derived: sum of 3 quarters · filed 2022-02-24 | -$80.23M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | -$8.07M 10-Q · filed 2021-05-05 | -$34.99M derived: sum of 2 quarters · filed 2022-02-24 | -$45.21M derived: sum of 3 quarters · filed 2022-02-24 | -$61.24M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | -$26.91M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$37.14M derived: sum of 2 quarters · filed 2022-02-24 | -$53.17M derived: sum of 3 quarters · filed 2022-02-24 | $26.88M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | -$10.22M 10-Q · filed 2020-11-06 | -$26.26M derived: sum of 2 quarters · filed 2020-11-06 | $53.79M 10-Q · filed 2020-11-06 | $35.59M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-06-30 | -$16.03M 10-Q · filed 2020-08-05 | $64.01M 10-Q · filed 2020-08-05 | $45.81M derived: sum of 3 quarters · filed 2021-02-24 | $48.96M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-03-31 | $80.05M 10-Q · filed 2020-05-08 | $61.85M derived: sum of 2 quarters · filed 2021-02-24 | $65.00M derived: sum of 3 quarters · filed 2021-02-24 | $39.13M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2018-12-31 | -$18.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$15.05M derived: sum of 2 quarters · filed 2021-02-24 | -$40.92M derived: sum of 3 quarters · filed 2021-02-24 | -$70.41M 10-K · filed 2021-02-24 | ||||
| 2018-09-30 | $3.15M 10-Q · filed 2019-11-05 | -$22.72M derived: sum of 2 quarters · filed 2019-11-05 | -$52.21M 10-Q · filed 2019-11-05 | -$44.84M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-06-30 | -$25.87M 10-Q · filed 2019-08-07 | -$55.36M 10-Q · filed 2019-08-07 | -$47.99M derived: sum of 3 quarters · filed 2020-02-25 | -$70.65M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-03-31 | -$29.49M 10-Q · filed 2019-05-09 | -$22.13M derived: sum of 2 quarters · filed 2020-02-25 | -$44.78M derived: sum of 3 quarters · filed 2020-02-25 | -$52.50M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2017-12-31 | $7.37M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$15.29M derived: sum of 2 quarters · filed 2020-02-25 | -$23.01M derived: sum of 3 quarters · filed 2020-02-25 | -$38.49M 10-K · filed 2020-02-25 | -$48.92M 10-K · filed 2018-02-28 | |||
| 2017-09-30 | -$22.65M 10-Q · filed 2018-11-05 | -$30.38M derived: sum of 2 quarters · filed 2018-11-05 | -$45.85M 10-Q · filed 2018-11-05 | |||||
| 2017-06-30 | -$7.72M 10-Q · filed 2018-08-07 | -$23.20M 10-Q · filed 2018-08-07 | ||||||
| 2017-03-31 | -$15.47M 10-Q · filed 2018-05-07 | |||||||
| 2016-12-31 | $45.13M 10-K · filed 2019-02-26 | $23.63M 10-K · filed 2017-03-01 | ||||||
| 2015-12-31 | -$17.59M 10-K · filed 2018-02-28 | |||||||
| 2014-12-31 | -$1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$7.63M derived: sum of 2 quarters · filed 2017-03-01 | -$12.67M derived: sum of 3 quarters · filed 2017-03-01 | -$16.42M 10-K · filed 2017-03-01 | ||||
| 2014-09-30 | -$6.28M 10-Q · filed 2014-11-10 | -$11.32M derived: sum of 2 quarters · filed 2014-11-10 | -$15.07M 10-Q · filed 2014-11-10 | |||||
| 2014-06-30 | -$5.04M 10-Q · filed 2014-08-01 | -$8.79M 10-Q · filed 2014-08-01 | ||||||
| 2013-12-31 | -$3.70M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | -$7.89M derived: sum of 2 quarters · filed 2016-03-08 | $89.12M derived: sum of 3 quarters · filed 2016-03-08 | $84.51M 10-K · filed 2016-03-08 | ||||
| 2013-09-30 | -$4.18M 10-Q · filed 2014-11-10 | $92.82M derived: sum of 2 quarters · filed 2014-11-10 | $88.21M 10-Q · filed 2014-11-10 | |||||
| 2013-06-30 | $97.00M 10-Q · filed 2014-08-01 | $92.39M 10-Q · filed 2014-08-01 | ||||||
| 2012-12-31 | -$8.59M 10-K · filed 2015-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |